Company Analysis

Veradermics, Incorporated (MANE)

NYSE: MANE · Pharmaceutical Preparations · New Haven, CT · filing with the SEC since 2020
Grade5.7
◀ Past 6.8● Present 6.4▶ Future 4.4
7 est.

Filings

58 filings since 2017 beside 43 insider forms · Non-accelerated filer and smaller reporting company and emerging growth company · read from EDGAR on Nov 13, 2026
Due nextNon-accelerated filer and smaller reporting company and emerging growth company
10-K Annual report for the fiscal year ending Dec 31, 2026Non-accelerated filers and smaller reporting companies have 90 days after the fiscal year ends. by Mar 31, 2027
10-Q Quarterly report for the quarter ending Mar 31, 2027Non-accelerated filers and smaller reporting companies have 45 days after the quarter ends; quarter ends are taken to the month end. by May 15, 2027

A deadline is the latest date the SEC's rules allow for its filer category. It is not a forecast of the day the company files. Last time, the results release (8-K item 2.02) came 41 days after the quarter ended.

Filings a yearinsider forms included
1211294
202020212023202420252026

2026 counts to Nov 13, 2026.

SEC letters: 3 in the last 36 months, the newest Apr 27, 2026.
Insider forms 43

Insider forms (3, 4, 5 and 144) are counted each year but not listed here; the people and their trades are on the Ownership tab.

FiledFormWhat it is, in plain wordsPeriodAsk
Nov 10, 2026 10-Q Quarterly report Sep 30, 2026
Nov 10, 2026 8-K items 2.02, 9.01 Results released · Current report
Nov 9, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Oct 19, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Oct 13, 2026 SCHEDULE 13G Large holder notice
Aug 21, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 14, 2026 EFFECT Registration effective
Aug 14, 2026 424B3 Shelf offering
Aug 14, 2026 SCHEDULE 13D/A Activist holder update, amended
Aug 11, 2026 10-Q Quarterly report Jun 30, 2026
Aug 11, 2026 8-K items 2.02, 9.01 Results released · Current report
Aug 7, 2026 S-1 Listing registration
Aug 6, 2026 SCHEDULE 13G Large holder notice
Jul 15, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
May 15, 2026 D Private placement notice
May 15, 2026 SCHEDULE 13G/A Large holder update, amended
May 12, 2026 10-Q Quarterly report Mar 31, 2026
May 12, 2026 8-K items 2.02, 9.01 Results released · Current report
May 7, 2026 SCHEDULE 13G Large holder notice
May 5, 2026 SCHEDULE 13D/A Activist holder update, amended
May 5, 2026 SCHEDULE 13D Activist holder notice
May 5, 2026 SCHEDULE 13D/A Activist holder update, amended
May 1, 2026 8-K items 1.01, 3.02, 9.01 Major agreement signed; Shares sold without registration · Current report
Apr 30, 2026 424B4 Offering prospectus
Apr 30, 2026 FWP Offering communication
Apr 29, 2026 EFFECT Registration effective
Apr 29, 2026 S-1MEF Listing registration, added shares
Apr 27, 2026 FWP Offering communication
Apr 27, 2026 CORRESP Reply to the SEC
Apr 27, 2026 CORRESP Reply to the SEC
Apr 27, 2026 S-1 Listing registration
Apr 27, 2026 8-K item 2.02 Results released · Current report
Apr 27, 2026 8-K items 7.01, 8.01, 9.01 Investor disclosure (Regulation FD); Other event · Current report
Apr 7, 2026 UPLOAD SEC comment letter
Apr 6, 2026 DRS Draft registration, confidential
Mar 30, 2026 10-K Annual report Dec 31, 2025
Mar 30, 2026 8-K items 2.02, 9.01 Results released · Current report
Feb 12, 2026 SCHEDULE 13D Activist holder notice
Feb 12, 2026 SCHEDULE 13G Large holder notice
Feb 11, 2026 SCHEDULE 13D Activist holder notice
40 of 58 shown

Every row opens the filing on EDGAR. The plain words are the site's own for each form and each 8-K item; the complete history, insider forms included, is on EDGAR.

SI Assistanton MANE · research, not advice